Skip to content

All you've got to do is call 0808 808 1010 0808 808 1010 Call free, 365 days a year

Cymraeg

Research

Current iGrants

I Grants Graphic

We fund research that highlights or meets the needs of cancer patients and their families, including cancer prevention research.

Our Innovation Grants (now called iGrants) are more than just innovation. We’d also support projects that implement great ideas, involve patients and public, influence policy and practice, and invest in the future. 

You can view our completed iGrant projects here.

2016, 2015

 

2017

The effects of trastuzumab treatment on cardiotoxicity in patients with breast cancer: a prospective study

Dr Aamer Sandoo, Bangor University
Start date: 
September 2017
Duration: 
12 months
Funding amount: 
£12,858

The Challenges of Cancer and Disability Study (CoCaDS)

Dr Dikaios Sakellariou, Cardiff University
Start date: 
June 2017
Duration: 
12 months
Funding amount: 
£26,342

The Empower Project: evaluating a patient designed tool to reduce harm from cancer-associated thrombosis

Professor Simon Noble, Cardiff University
Start date: 
April 2017
Duration: 
12 months
Funding amount: 
£29,963

Community based Point of care (PoC) white cell count testing to improve pathways for cancer patients with sepsis whilst receiving chemotherapy: a pilot study

Richard Adams, Cardiff University, Velindre Cancer Centre, Wales Cancer Trials Unit
Start date: 
April 2017
Duration: 
12 months
Funding amount: 
£30,000

Pragmatic development of a tool to help men report Genitourinary Cancer-related Lymphoedema

Melanie Thomas, ABMU Health Board
Start date: 
April 2017
Duration: 
12 months
Funding amount: 
£28,000

Factors influencing patient choice of bladder reconstruction following radical cystectomy

Professor Phil Reed, Swansea University
Start date: 
April 2017
Duration: 
12 months
Funding amount: 
£29,963

2016

Nutrition and Food Safety intervention

Dr Ellen Evans, Cardiff Metropolitan University (Joint funded with SEWAHSP)
Start date: September 2016
Duration: 12 months
Funding amount: £16,095

The human cost of cancer: addressing physical, emotional & financial implications of facing cancer when living alone

Dr Sofia Vougioukalou, Cardiff University
Start date: December 2016
Duration: 12 months
Funding amount: £29,700

Feasibility study of a behavioural intervention to reduce fatigue in women undergoing radiotherapy for curable breast cancer

Dr Nick Courtier, Cardiff University
Start date: July 2016
Duration: 12 months
Funding amount: £29,754

PARiS (Physiotherapy and Anterior Resection Syndrome)

Mrs Julie Cornish, Cwm Taf University Health Board
Start date: May 2016
Duration: 12 months
Funding amount: £27,767

Identification and Validation of a Low-cost, high throughput Biomarker Assay for Lung Cancer Status, Stage and type

Dr Keir Lewis, Hywel Dda University Health Board and Swansea University and
Professor Luis Mur, Aberystwyth University
Start date: May 2016
Duration: 12 months
Funding amount: £28,527

FACT: Factors associated with late presentation in patients with lung cancer: A patient centred approach

Dr Gareth Collier, Hywel Dda University Health Board and Miss Rachel Roberts, Hywel Dda University Health Board and Swansea University
Start date: April 2016
Duration: 12 months
Funding amount: £26,584

Optimised and Equitable care for Welsh Cancer Patients undergoing emergency surgery

Dr Rachael Barlow, Cardiff and Vale University Health Board
Start date: April 2016
Duration: 12 months
Funding amount: £30,000

The perception of palliative patients towards new treatments for peritonealmetastases

Mrs Julie Cornish
Start date: April 2016
Duration: 12 months
Funding amount: £28,000

2015

An exploratory study of the ability of F-FDG PET to predict response to palliative chemotherapy in patients with poor-prognosis, recurrent/metastatic head and neck cancer

Professor John Chester, Cardiff University
Start date: April 2015 (Extended to Dec 2017)
Duration: 20 months
Funded amount: £29,870

Evaluation of risk factors associated with the development of endometrial cancer in patients taking Tamoxifen

Dr Lavinia Margarit, Princess of Wales Hospital and Swansea University
Start date: April 2015
Duration: 12 months (Extended to 2018)
Funded amount: £30,000

An investigation into contemporary factors influencing the outcome of multidisciplinary stage directed treatment of pancreatic cancer

Dr Nicholas Mowbray, Singleton Hospital (Supported by Amser Justin Time)
Start date: March 2015 (Extended to March 2018)
Duration: 24 months
Funded amount: £8,496